News

  • News Archive
11 June 2013

Cobra Biologics and Novolytics Unveil Successful Development of Bacteriophages Against Bacterial Infection

28 May 2013

Cobra and Recopharma Enter agreement to utilise Cobra’s Cell Line Development Service- MaxXpress

14 May 2013

Cobra Biologics and Vaccibody Sign Agreement to Manufacture DNA Vaccine

26 March 2013

Cobra Biologics Wins Innovation Grant

For further information, please contact:

Julian Hanak
Commercial Services
Tel: +44 (0) 1782 714 181

   

 

News Alert

View privacy policy